Evidence map›Paper›PMID 34110897›Full record

ArticleCirculation research2021

Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease.

Richard A Baylis, Nicholas L Smith, Derek Klarin, Eri Fukaya

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Observational
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. International journal of molecular sciences · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Richard A BaylisDepartment of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, CA (R.A.B., E.F.).
Nicholas L SmithDepartment of Epidemiology, University of Washington, Seattle (N.L.S.).
Derek KlarinDivision of Vascular Surgery, University of Florida College of Medicine, Gainesville (D.K.).
Eri FukayaDepartment of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, CA (R.A.B., E.F.).
Stanford University · USBroad Institute · USUniversity of Washington · US

Funding

Structural and Nucleotide Variation as Genomic Risks for Venous Thrombosis: TOPMED and INVENT CollaborationR01HL154385 · NHLBI · UNIVERSITY OF WASHINGTON · PI PANKRATZ, NATHAN D, SMITH, NICHOLAS L · 2020 to 2023
$3.0M
Population genomic variation, functional biology, and the risk of venous thrombosisR01HL134894 · NHLBI · UNIVERSITY OF WASHINGTON · PI LOWENSTEIN, CHARLES J, SMITH, NICHOLAS L · 2017 to 2020
$2.9M
IL1β Promotes Atheroprotective Changes in Late Stage Atherosclerotic LesionsF30HL136188 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLIS, RICHARD · 2017 to 2020
$144k
NHLBI NIH HHS F30 HL136188NHLBI NIH HHS R01 HL134894NHLBI NIH HHS R01 HL154385
6 · The paper itself

Abstract

Venous disease is a term that broadly covers both venous thromboembolic disease and chronic venous disease. The basic pathophysiology of venous thromboembolism and chronic venous disease differ as venous thromboembolism results from an imbalance of hemostasis and thrombosis while chronic venous disease occurs in the setting of tissue damage because of prolonged venous hypertension. Both diseases are common and account for significant mortality and morbidity, respectively, and collectively make up a large health care burden. Despite both diseases having well-characterized environmental components, it has been known for decades that family history is an important risk factor, implicating a genetic element to a patient's risk. Our understanding of the pathogenesis of these diseases has greatly benefited from an expansion of population genetic studies from pioneering familial studies to large genome-wide association studies; we now have multiple risk loci for each venous disease. In this review, we will highlight the current state of knowledge on the epidemiology and genetics of venous thromboembolism and chronic venous disease and directions for future research.

Indexed as

Chronic DiseaseFamilyGenetic Association StudiesGenome-Wide Association StudyHumansRisk FactorsUnited StatesVaricose VeinsVenous InsufficiencyVenous ThromboembolismVenous Thrombosisgeneticsgenome wide association studyvaricose veinvenous insufficiencyvenous thromboembolismvenous thrombosis

Identifiers

PMID34110897
PMCPMC8487638
OpenAlexW3170034452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.